March 15 , 2008 - Itamar Medical Inc. is pleased to report that the Centers for Medicare and Medicaid Services (CMS) has released (March 14th, 2008) its final National Coverage Decision (NCD) where it has decided to cover the Watch-PAT for home diagnosis of obstructive sleep apnea. This decision will make the Watch-PAT available to Medicare beneficiaries nationwide.
The CMS Final Decision Memorandum discussed the Watch-PAT and the clinical evidence supporting its efficacy in very positive detail. Of particular note is CMS’s response to comments that asserted that the Watch-PAT is a useful diagnostic tool and should not be required to provide additional data under Coverage with Evidence Development... Itamar Medical's Press Release -
Blog Archive
-
▼
2008
(56)
-
▼
April
(13)
- Arena : Phase 2b Clinical Trial of APD125 for the ...
- Medtronic : Agreement to Acquire Restore Medical
- Astro-Med : Home Sleep Screener as Medicare Issues...
- Southern Home Medical Equipment : Another Record M...
- Meda : exclusive world-wide commercialization righ...
- Neurogen : $30.6 Million Financing to Advance Clin...
- BTG : Positive Results from First Study Investigat...
- Itamar Medical : Watch-PAT to be included as an a...
- SleepEx : Agreement with the Atlanta School of Sle...
- SOMAXON PHARMACEUTICALS : NEW DRUG APPLICATION FOR...
- Graymark Healthcare : Letter of Intent to Acquire ...
- Jazz Pharmaceuticals, Inc. : Development Pipeline ...
- Philips : completion of Respironics acquisition
-
▼
April
(13)
Thursday, April 17, 2008
Itamar Medical : Watch-PAT to be included as an accepted ambulatory device for Medicare and Medicaid beneficiaries
Libellés :
Itamar Medical,
obstructive sleep apnea,
sleep diagnostic